Fresenius Medical Care dividend and valuation
Valuation
Fresenius Medical Care paid €1.49 per share in dividends over the last 12 months (yield 4.0%). Last ex-dividend date: May 22, 2026. The P/E ratio is 12.3. The average price target of 17 analysts is €39.39.
Data as of November 22, 2026
Fresenius Medical Care compared with similar companies
Fresenius Medical Care's P/E (trailing 12 months): 12.3, −30% against the median of a group of 10 similar companies (17.6).
| Metric | Fresenius Medical Care | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 12.3 | 17.6 | 12.5 – 32.4 | Low |
| Forward P/E | 9.87 | 13.2 | 9.61 – 18.7 | Middle |
| EV/EBITDA | 7.61 | 11.8 | 8.14 – 16.9 | Low |
| Price/book | 0.76 | 2.53 | 1.38 – 3.91 | Low |
| Price/sales | 0.50 | 1.23 | 0.63 – 2.70 | Low |
| Gross margin | 26.5% | 27.7% | 25.0% – 44.9% | Middle |
| Operating margin | 10.1% | 10.1% | 8.9% – 17.7% | Middle |
| Net margin | 4.2% | 6.6% | 4.5% – 7.9% | Low |
| ROE | 7.8% | 12.8% | 9.3% – 17.8% | Low |
| Debt/equity | 0.79 | 0.89 | 0.68 – 2.03 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Fresenius Medical Care: valuation over time
On the latest fiscal year's earnings (2025), Fresenius Medical Care's P/E today is 11.2, below the median of its last 10 fiscal years (17.2; between 8.78 and 24.1 from 2016 to 2025). Relative to earnings, the stock costs less than it used to. The dividend yield (4.0%) is above the median of the last 10 fiscal years (2.2%).
| Fiscal year | Price at year end | Earnings per share | P/E | Dividend per share | Yield |
|---|---|---|---|---|---|
| 2025 | €40.76 | €3.36 | 12.1 | €1.49 | 3.7% |
| 2024 | €44.16 | €1.83 | 24.1 | €1.44 | 3.3% |
| 2023 | €37.96 | €1.70 | 22.3 | €1.19 | 3.1% |
| 2022 | €30.57 | €2.30 | 13.3 | €1.12 | 3.7% |
| 2021 | €57.14 | €3.31 | 17.3 | €1.35 | 2.4% |
| 2020 | €68.20 | €3.96 | 17.2 | €1.34 | 2.0% |
| 2019 | €65.96 | €3.96 | 16.7 | €1.20 | 1.8% |
| 2018 | €56.64 | €6.45 | 8.78 | €1.17 | 2.1% |
| 2017 | €87.78 | €4.16 | 21.1 | €1.06 | 1.2% |
| 2016 | €80.45 | €3.73 | 21.6 | €0.96 | 1.2% |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- €9.76B
- Enterprise value
- €20.53B
- PEG
- 0.91
- EV/revenue
- 1.05
Profitability and growth
- ROA
- 3.9%
- ROIC
- 5.0%
- Revenue growth (year over year)
- 1.1%
- Earnings growth (year over year)
- -35.4%
Financial health
- Total cash
- €1.1B
- Total debt
- €10.9B
- Current ratio
- 0.99
- Quick ratio
- 0.58
Dividends
- Annual dividend per share
- €1.49
- Dividend yield
- 4.0%
- Payout ratio
- 48.9%
- Ex-dividend date
- May 22, 2026
Analysts and estimates
- Average price target
- €39.39
- Median price target
- €37.50
- High price target
- €62.00
- Low price target
- €28.00
- Analysts with a price target
- 17
- Consensus
- Hold
- Forward EPS
- €3.81
- EPS estimate, current year
- €4.04
Shares and trading
- Beta
- 0.79
- Average volume
- 968.73K
- Shares outstanding
- 259.51M
- Float
- 205.21M
- Institutional ownership
- 53.4%
- Insider ownership
- 20.0%
